BAY1163877 / 19774 ROCOCO

Status: Active Trial | Marker: FGFR Title Phase 1 study of the combination of rogaratinib with copanlisib in patients with FGFR-positive, locally advanced or metastatic solid tumors. Study Number NCT02974725 Indication Dose escalation part: locally advanced or...

FIND

Status: Active Trial | Marker: FGFR Title A phase II trial to evaluate efficacy and safety of erdafitinib in patients with advanced squamous NSCLC (sqNSCLC) harboring FGFR genetic alterations after relapse of standard therapy. Study Number EudraCT 2018-000399-13...